<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcpregnancychildbirth&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Pregnancy and Childbirth - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpregnancychildbirth/</link>
        <description>The latest research articles published by BMC Pregnancy and Childbirth</description>
        <dc:date>2009-11-27T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/55" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/54" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/53" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/52" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/51" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/50" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/49" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/48" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/47" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/46" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/55">
        <title>Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group</title>
        <description>Background:
Postpartum haemorrhage (PPH) is a major cause of maternal mortality and morbidity worldwide. Recent publications have noted an increasing trend in incidence over time. The international PPH collaboration was convened to explore the observed trends and to set out actions to address the factors identified.
Methods:
We reviewed available data sources on the incidence of PPH over time in Australia, Belgium, Canada, France, the UK and the USA. Where information was available, the incidence of PPH was stratified by cause.
Results:
We observed an increasing trend in PPH, using heterogeneous definitions, in Australia, Canada, the UK and the USA. The observed increase in PPH in Australia, Canada and the USA was limited solely to PPH coded as immediate/atonic. We noted increasing rates of severe adverse outcomes due to haemorrhage in Australia, Canada, the UK and the USA.
Conclusions:
Key Recommendations1.	Future revisions of the International Classification of Diseases should include separate codes for atonic PPH and PPH immediately following childbirth that is due to other causes. Also, additional codes are required for placenta accreta/percreta/increta.2.	Definitions of PPH should be unified; further research is required to investigate how definitions are applied in practice to the coding of data.3.	Additional improvement in the collection of data concerning PPH is required, specifically including a measure of severity.4.	Further research is required to determine whether an increased rate of reported PPH is also observed in other countries, and to further investigate potential risk factors including increased duration of labour, obesity and changes in second and third stage management practice.5.	Training should be provided to all staff involved in maternity care concerning assessment of blood loss and the monitoring of women after childbirth. This is key to reducing the severity of PPH and preventing any adverse outcomes.6.	Clinicians should be more vigilant given the possibility that the frequency and severity of PPH has in fact increased. This applies particularly to small hospitals with relatively few deliveries where management protocols may not be defined adequately and drugs or equipment may not be on hand to deal with unexpected severe PPH.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/55</link>
                <dc:creator>Marian Knight</dc:creator>
                <dc:creator>William Callaghan</dc:creator>
                <dc:creator>Cynthia Berg</dc:creator>
                <dc:creator>Sophie Alexander</dc:creator>
                <dc:creator>Marie-Helene Bouvier-Colle</dc:creator>
                <dc:creator>Jane Ford</dc:creator>
                <dc:creator>K Joseph</dc:creator>
                <dc:creator>Gwyneth Lewis</dc:creator>
                <dc:creator>Robert Liston</dc:creator>
                <dc:creator>Christine Roberts</dc:creator>
                <dc:creator>Jeremy Oats</dc:creator>
                <dc:creator>James Walker</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:55</dc:source>
        <dc:date>2009-11-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-55</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>55</prism:startingPage>
        <prism:publicationDate>2009-11-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/54">
        <title>Newborn care practices among slum dwellers in Dhaka, Bangladesh: a quantitative and qualitative exploratory study</title>
        <description>Background:
Urbanization is occurring at a rapid pace, especially in low-income countries. Dhaka, Bangladesh, is estimated to grow to 50 million by 2015, with 21 million living in urban slums. Although health services are available, neonatal mortality is higher in slum areas than in urban non-slum areas. The Manoshi program works to improve maternal, newborn, and child health in urban slums in Bangladesh. This paper describes newborn care practices in urban slums in Dhaka and provides program recommendations.
Methods:
A quantitative baseline survey was conducted in six urban slum areas to measure newborn care practices among recently delivered women (n = 1,256). Thirty-six in-depth semi-structured interviews were conducted to explore newborn care practices among currently pregnant women (n = 18) and women who had at least one delivery (n = 18).
Results:
In the baseline survey, the majority of women gave birth at home (84%). Most women reported having knowledge about drying the baby (64%), wrapping the baby after birth (59%), and cord care (46%). In the in-depth interviews, almost all women reported using sterilized instruments to cut the cord. Babies are typically bathed soon after birth to purify them from the birth process. There was extensive care given to the umbilical cord including massage and/or applying substances, as well as a variety of practices to keep the baby warm. Exclusive breastfeeding was rare; most women reported first giving their babies sweet water, honey and/or other foods.
Conclusion:
These reported newborn care practices are similar to those in rural areas of Bangladesh and to urban and rural areas in the South Asia region. There are several program implications. Educational messages to promote providing newborn care immediately after birth, using sterile thread, delaying bathing, and ensuring dry cord care and exclusive breastfeeding are needed. Programs in urban slum areas should also consider interventions to improve social support for women, especially first time mothers. These interventions may improve newborn survival and help achieve MDG4.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/54</link>
                <dc:creator>Allisyn Moran</dc:creator>
                <dc:creator>Nuzhat Choudhury</dc:creator>
                <dc:creator>Nazib Uz Zaman Khan</dc:creator>
                <dc:creator>Zunaid Ahsan Karar</dc:creator>
                <dc:creator>Tasnuva Wahed</dc:creator>
                <dc:creator>Sabina Rashid</dc:creator>
                <dc:creator>M.  Ashraful Alam</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:54</dc:source>
        <dc:date>2009-11-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-54</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>54</prism:startingPage>
        <prism:publicationDate>2009-11-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/53">
        <title>Surprisingly low compliance to local guidelines for risk factor based screening for gestational diabetes mellitus - A population-based study.</title>
        <description>Background:
Screening for gestational diabetes mellitus (GDM) is routine during pregnancy in many countries in the world. The screening programs are either based on general screening offered to all pregnant women or risk factor based screening stipulated in local clinical guidelines. The aims of this study were to investigate: 1) the compliance with local guidelines of screening for GDM and 2) the outcomes of pregnancy and birth in relation to risk factors of GDM and whether or not exposed to oral glucose tolerance test (OGTT).
Methods:
This study design was a population-based retrospective cross-sectional study of 822 women. A combination of questionnaire data and data collected from medical records was applied. Compliance to the local guidelines of risk factor based screening for GDM was examined and a comparison of outcomes of pregnancy and delivery in relation to risk factor groups for GDM was performed.
Results:
Of the 822 participants, 257 (31.3%) women fulfilled at least one criterion for being exposed to screening for GDM according to the local clinical guidelines. However, only 79 (30.7%) of these women were actually exposed to OGTT and of those correctly exposed for screening, seven women were diagnosed with GDM. Women developing risk factors for GDM during pregnancy had a substantially increased risk of giving birth to an infant with macrosomia.
Conclusion:
Surprisingly low compliance with the local clinical guidelines for screening for GDM during pregnancy was found. Furthermore, the prevalence of the risk factors of GDM in our study was almost doubled compared to previous Swedish studies. Pregnant women developing risk factors of GDM during pregnancy were found to be at substantially increased risk of giving birth to an infant with macrosomia. There is a need of actions improving compliance to the local guidelines.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/53</link>
                <dc:creator>Margareta Persson</dc:creator>
                <dc:creator>Anna Winkvist</dc:creator>
                <dc:creator>Ingrid Mogren</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:53</dc:source>
        <dc:date>2009-11-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-53</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>53</prism:startingPage>
        <prism:publicationDate>2009-11-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/52">
        <title>Residential mobility during pregnancy in the north of England</title>
        <description>Background:
Many epidemiological studies assign exposure to an individual&apos;s residence at a single time point, such as birth or death. This approach makes no allowance for migration and may result in exposure error, leading to reduced study power and biased risk estimates. Pregnancy outcomes are less susceptible to this bias, however data from North American populations indicate that pregnant women are a highly mobile group. We assessed mobility in pregnant women in the north of England using data from the Northern Congenital Abnormality Survey (NorCAS).
Methods:
Data were extracted from NorCAS for 1985 to 2003. Eligible cases had a gestational age at delivery of &#8805; 24 weeks (a viable delivery) (n = 11 559). We assessed mobility between booking appointment (average gestational age 13 weeks) and delivery for pregnancies where the address at booking appointment and delivery were known. The impacts on mobility of maternal age and area-level socio-economic indicators were explored using standard descriptive statistics. A sensitivity analysis and a small validation exercise were undertaken to assess the impact of missing data on the estimate of mobility.
Results:
Out of 7 919 eligible cases for whom addresses at booking and delivery were known, 705 (8.9% (95% CI 8.3 - 9.5)) moved between booking and delivery; the mean and median moving distance was 9.7 and 1.4 km respectively. Movers were significantly younger (25.4 versus 27.3 years, p &lt; 0.01) and lived in more deprived areas (index of multiple deprivation score 38.3 versus 33.7, p &lt; 0.01) than non movers.
Conclusion:
Mobility in the north of England (9%) is considerably lower than that reported in North America and the only other study from the UK (23%). Consistent with other studies, mobility was related to maternal age and socio-economic status, and the majority of moves were over a relatively short distance. Although this population appears relatively stable, the mobility we have observed may still introduce misclassification or error into an exposure assessment relying solely on postcode at delivery, and migration should still therefore be considered a potential source of bias in future studies.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/52</link>
                <dc:creator>Susan Hodgson</dc:creator>
                <dc:creator>Mark Shirley</dc:creator>
                <dc:creator>Mary Bythell</dc:creator>
                <dc:creator>Judith Rankin</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:52</dc:source>
        <dc:date>2009-11-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-52</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>52</prism:startingPage>
        <prism:publicationDate>2009-11-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/51">
        <title>Maternal morbidity in the first year after childbirth in Mombasa Kenya; a needs assessment</title>
        <description>Background:
In sub-Saharan Africa, few services specifically address the needs of women in the first year after childbirth. By assessing the health status of women in this period, key interventions to improve maternal health could be identified. There is an underutilised opportunity to include these interventions within the package of services provided for woman-child pairs attending child-health clinics.
Methods:
This needs assessment entailed a cross-sectional survey with 500 women attending a child-health clinic at the provincial hospital in Mombasa, Kenya. A structured questionnaire, clinical examination, and collection of blood, urine, cervical swabs and Pap smear were done. Women&apos;s health care needs were compared between the early (four weeks to two months after childbirth), middle (two to six months) and late periods (six to twelve months) since childbirth.
Results:
More than one third of women had an unmet need for contraception (39%, 187/475). Compared with other time intervals, women in the late period had more general health symptoms such as abdominal pain, fever and depression, but fewer urinary or breast problems. Over 50% of women in each period had anaemia (Hb &lt;11 g/l; 265/489), with even higher levels of anaemia in those who had a caesarean section or had not received iron supplementation during pregnancy. Bacterial vaginosis was present in 32% (141/447) of women, while 1% (5/495) had syphilis, 8% (35/454) Trichomonas vaginalis and 11% (54/496) HIV infection.
Conclusion:
Throughout the first year after childbirth, women had high levels of morbidity. Interface with health workers at child health clinics should be used for treatment of anaemia, screening and treatment of reproductive tract infections, and provision of family planning counselling and contraception. Providing these services during visits to child health clinics, which have high coverage both early and late in the year after childbirth, could make an important contribution towards improving women&apos;s health.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/51</link>
                <dc:creator>Matthew Chersich</dc:creator>
                <dc:creator>Nicole Kley</dc:creator>
                <dc:creator>Stanley Luchters</dc:creator>
                <dc:creator>Carol Njeru</dc:creator>
                <dc:creator>Elodie Yard</dc:creator>
                <dc:creator>Mary Othigo</dc:creator>
                <dc:creator>Marleen Temmerman</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:51</dc:source>
        <dc:date>2009-11-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-51</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>51</prism:startingPage>
        <prism:publicationDate>2009-11-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/50">
        <title>Developing and pre-testing a decision board to facilitate informed choice about delivery approach in uncomplicated pregnancy</title>
        <description>Background:
The rate of caesarean sections is increasing worldwide, yet medical literature informing women with uncomplicated pregnancies about relative risks and benefits of elective caesarean section (CS) compared with vaginal delivery (VD) remains scarce. A decision board may address this gap, providing systematic evidence-based information so that patients can more fully understand their treatment options. The objective of our study was to design and pre-test a decision board to guide clinical discussions and enhance informed decision-making related to delivery approach (CS or VD) in uncomplicated pregnancy.
Methods:
Development of the decision board involved two preliminary studies to determine women&apos;s preferred mode of risk presentation and a systematic literature review for the most comprehensive presentation of medical risks at the time (VD and CS). Forty women were recruited to pre-test the tool. Eligible subjects were of childbearing age (18-40 years) but were not pregnant in order to avoid raising the expectation among pregnant women that CS was a universally available birth option. Women selected their preferred delivery approach and completed the Decisional Conflict Scale to measure decisional uncertainty before and after reviewing the decision board. They also answered open-ended questions reflecting what they had learned, whether or not the information had helped them to choose between birth methods, and additional information that should be included. Descriptive statistics were used to analyse sample characteristics and women&apos;s choice of delivery approach pre/post decision board. Change in decisional conflict was measured using Wilcoxon&apos;s sign rank test for each of the three subscales.
Results:
The majority of women reported that they had learned something new (n = 37, 92%) and that the tool had helped them make a hypothetical choice between delivery approaches (n = 34, 85%). Women wanted more information about neonatal risks and personal experiences. Decisional uncertainty decreased (p &lt; 0.001) and perceived effectiveness of decisions increased (p &lt; 0.001) post-intervention.
Conclusion:
Non-pregnant women of childbearing age were positive about the decision board and stated their hypothetical delivery choices were informed by risk presentation, but wanted additional information about benefits and experiences. This study represents a preliminary but integral step towards ensuring women considering delivery approaches in uncomplicated pregnancies are fully informed.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/50</link>
                <dc:creator>Jill Milne</dc:creator>
                <dc:creator>Amiram Gafni</dc:creator>
                <dc:creator>Diane Lu</dc:creator>
                <dc:creator>Stephen Wood</dc:creator>
                <dc:creator>Reg Sauve</dc:creator>
                <dc:creator>Sue Ross</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:50</dc:source>
        <dc:date>2009-10-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-50</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>50</prism:startingPage>
        <prism:publicationDate>2009-10-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/49">
        <title>Mary Crosse Project: Systematic reviews and grading the value of neonatal tests in predicting long term outcomes</title>
        <description>Background:
Events before birth, condition at birth, events immediately following birth, and condition in early childhood are linked together, and have implications for health and disease in adulthood. At present, there is lack of clarity about the tests that purport to link these various stages. This is partly because there is paucity of collated information about the best strategies for predicting longer-term outcomes before (using tests in fetal period) or after birth (using tests in neonatal period, infancy as well as early childhood).Methods/DesignA series of systematic reviews and meta-analyses will be undertaken to determine, amongst neonates, the ability of various tests and measures to predict infant, childhood and adult outcomes. We will search Medline, Embase, Cochrane Library, MEDION, citation lists of review articles and eligible primary articles and will contact experts in the field. Independent reviewers will select studies, extract data and assess study quality according to established criteria. Language restrictions will not be applied. Data synthesis will involve meta-analysis (where appropriate), exploration of heterogeneity and publication bias. Evidence collated will be graded for its quality to support decision making.DiscussionThe project will collate, synthesise and evaluate the available evidence concerning the value of tests of neonatal wellbeing to predict long term outcomes. The systematic reviews will assess the quality of available evidence and identify tests with the strongest association with outcomes, and assess their economic value. The output of this project will help formulate practice recommendations.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/49</link>
                <dc:creator>Gemma Malin</dc:creator>
                <dc:creator>Rachel Morris</dc:creator>
                <dc:creator>Khalid Khan</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:49</dc:source>
        <dc:date>2009-10-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-49</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>49</prism:startingPage>
        <prism:publicationDate>2009-10-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/48">
        <title>Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania)</title>
        <description>Background:
Retained placenta is one of the common causes of maternal mortality in developing countries where access to appropriate obstetrical care is limited. Current treatment of retained placenta is manual removal of the placenta under anaesthesia, which can only take place in larger health care facilities. Medical treatment of retained placenta with prostaglandins E1 (misoprostol) could be cost-effective and easy-to-use and could be a life-saving option in many low-resource settings. The aim of this study is to assess the efficacy and safety of sublingually administered misoprostol in women with retained placenta in a low resource setting.
Methods:
Design: Multicentered randomised, double-blind, placebo-controlled trial, to be conducted in 5 hospitals in Tanzania, Africa.Inclusion criteria: Women with retained placenta, at a gestational age of 28 weeks or more and blood loss less than 750 ml, 30 minutes after delivery of the newborn despite active management of third stage of labour.Trial Entry &amp; Randomisation &amp; Study Medication: After obtaining informed consent, eligible women will be allocated randomly to the treatment groups using numbered envelopes that will be randomized in variable blocks containing identical capsules with either 800 microgram of misoprostol or placebo. The drugs will be given sublingually. The women, maternal care providers and researchers will be blinded to treatment allocation.Sample Size: 117 women, to show a 40% reduction in manual removals of the placenta (p = 0.05, 80% power). The randomization will be misoprostol: placebo = 2:1Primary Study Outcome: Expulsion of the placenta without manual removal. Secondary outcome is the number of blood transfusions.DiscussionThis is a protocol for a randomized trial in a low resource setting to assess if medical treatment of women with retained placenta with misoprostol reduces the incidence of manual removal of the placenta.Clinical Trial RegistrationCurrent Controlled Trials ISRCTN16104753</description>
        <link>http://www.biomedcentral.com/1471-2393/9/48</link>
                <dc:creator>Heleen van Beekhuizen</dc:creator>
                <dc:creator>Andrea Pembe</dc:creator>
                <dc:creator>Heiner Fauteck</dc:creator>
                <dc:creator>Fred Lotgering</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:48</dc:source>
        <dc:date>2009-10-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-48</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>48</prism:startingPage>
        <prism:publicationDate>2009-10-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/47">
        <title>A case study evaluation of implementation of a care pathway to support normal birth in one English birth centre: anticipated benefits and unintended consequences </title>
        <description>Background:
The policy drive for the UK National Health Service (NHS) has focused on the need for high quality services informed by evidence of best practice. The introduction of care pathways and protocols to standardise care and support implementation of evidence into practice has taken place across the NHS with limited evaluation of their impact. A multi-site case study evaluation was undertaken to assess the impact of use of care pathways and protocols on clinicians, service users and service delivery. One of the five sites was a midwifery-led Birth Centre, where an adapted version of the All Wales Clinical Pathway for Normal Birth had been implemented.
Methods:
The overarching framework was realistic evaluation. A case study design enabled the capture of data on use of the pathway in the clinical setting, use of multiple methods of data collection and opportunity to study and understand the experiences of clinicians and service users whose care was informed by the pathway. Women attending the Birth Centre were recruited at their 36 week antenatal visit. Episodes of care during labour were observed, following which the woman and the midwife who cared for her were interviewed about use of the pathway. Interviews were also held with other key stakeholders from the study site. Qualitative data were content analysed.
Results:
Observations were undertaken of four women during labour. Eighteen interviews were conducted with clinicians and women, including the women whose care was observed and the midwives who cared for them, senior midwifery managers and obstetricians. The implementation of the pathway resulted in a number of anticipated benefits, including increased midwifery confidence in skills to support normal birth and promotion of team working. There were also unintended consequences, including concerns about a lack of documentation of labour care and negative impact on working relationships with obstetric and other midwifery colleagues. Women were unaware their care was informed by a care pathway.
Conclusion:
Care pathways are complex interventions which generate a number of consequences for practice. Those considering introduction of pathways need to ensure all relevant stakeholders are engaged with this and develop robust evaluation strategies to accompany implementation.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/47</link>
                <dc:creator>Debra Bick</dc:creator>
                <dc:creator>Jo Rycroft-Malone</dc:creator>
                <dc:creator>Marina Fontenla</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:47</dc:source>
        <dc:date>2009-10-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-47</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>47</prism:startingPage>
        <prism:publicationDate>2009-10-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/46">
        <title>Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women</title>
        <description>Background:
Economic theory provides the philosophical foundation for valuing costs in judging medical and public health interventions. When evaluating smoking cessation interventions, accurate data on costs are essential for understanding resource consumption. Smoking cessation interventions, for which prior data on resource costs are typically not available, present special challenges. We develop a micro-costing methodology for estimating the real resource costs of outreach motivational interviewing (MI) for smoking cessation and relapse prevention among low-income pregnant women and report results from a randomized controlled trial (RCT) employing the methodology. Methodological standards in cost analysis are necessary for comparison and uniformity in analysis across interventions. Estimating the costs of outreach programs is critical for understanding the economics of reaching underserved and hard-to-reach populations.
Methods:
Randomized controlled trial (1997-2000) collecting primary cost data for intervention. A sample of 302 low-income pregnant women was recruited from multiple obstetrical sites in the Boston metropolitan area. MI delivered by outreach health nurses vs. usual care (UC), with economic costs as the main outcome measures.
Results:
The total cost of the MI intervention for 156 participants was $48,672 or $312 per participant. The total cost of $311.8 per participant for the MI intervention compared with a cost of $4.82 per participant for usual care, a difference of $307 ([CI], $289.2 to $322.8). The total fixed costs of the MI were $3,930 and the total variable costs of the MI were $44,710. The total expected program costs for delivering MI to 500 participants would be 147,430, assuming no economies of scale in program delivery. The main cost components of outreach MI were intervention delivery, travel time, scheduling, and training.
Conclusion:
Grounded in economic theory, this methodology systematically identifies and measures resource utilization, using a process tracking system and calculates both component-specific and total costs of outreach MI. The methodology could help improve collection of accurate data on costs and estimates of the real resource costs of interventions alongside clinical trials and improve the validity and reliability of estimates of resource costs for interventions targeted at underserved and hard-to-reach populations.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/46</link>
                <dc:creator>Jennifer Prah Ruger</dc:creator>
                <dc:creator>Karen Emmons</dc:creator>
                <dc:creator>Margaret Kearney</dc:creator>
                <dc:creator>Milton Weinstein</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:46</dc:source>
        <dc:date>2009-09-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-46</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>46</prism:startingPage>
        <prism:publicationDate>2009-09-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
